About: As of June 11, 2026, KalVista Pharmaceuticals, Inc. was taken private. KalVista Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops oral therapies for rare diseases in worldwide markets. It offers sebetralstat, a novel, oral, on-demand treatment for hereditary angioedema (HAE), and an oral Factor XIIa inhibitor program. KalVista Pharmaceuticals, Inc. was formerly known as KalVista Pharmaceuticals Ltd. and changed its name to KalVista Pharmaceuticals, Inc. in November 2016. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts. As of June 11, 2026, KalVista Pharmaceuticals, Inc. operates as a subsidiary of Chiesi Farmaceutici S.p.A.
Sector: Healthcare
Industry: Biotechnology
Latest price: $27.00 (+0.04%)
Status: Delisted — removed_from_provider. This asset is no longer trading; historical data is shown.
KALV NASDAQ Kalvista Pharmaceuticals Inc
Kalvista Pharmaceuticals Inc share price
KALV price activity
Last Price
Change (24hr)
USD
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
KALV price performance
KALV details
KALV Market Signals